Market Place
Sourcing Support
CHMP Maintains Negative Opinion on Translarna™ Reexamination
18 Oct 2024 //
PR NEWSWIRE
PTC Therapeutics Reports Q2 2024 Results And Corporate Update
08 Aug 2024 //
PR NEWSWIRE
EMA committee recommends non-renewal conditional marketing authorisation of DMD
12 Jul 2024 //
PHARMABIZ
CHMP Issues Negative Opinion On Translarna Following European Commission Review
28 Jun 2024 //
PR NEWSWIRE
PTC`s re-examination bid for Translarna falls short in Europe
25 Jan 2024 //
FIERCE PHARMA
EMA recommends non-renewal of authorisation of medicine Translarna
15 Sep 2023 //
EMA
NICE signs off on rare disease therapies from Alnylam, PTC
20 Jan 2023 //
FIERCE PHARMA
PTC to Present Clinical & Real-World Evidence on Translarna at Annual Congress
11 Oct 2022 //
PRNEWSWIRE
Translarna not approved by NICE for DMD on NHS
03 Oct 2022 //
PHARMAPHORUM
PTC Tx to Host Call to Review Topline Results from Study 041 for Translarna
20 Jun 2022 //
PRNEWSWIRE
ANVISA grants expanded approval to Translarna to include ambulatory patients
27 Oct 2021 //
PHARMABIZ
PTC Announces Expansion of Translarna™ Label to Include Ambulatory Patients
25 Oct 2021 //
PRNEWSWIRE
STRIDE Data Show Translarna Delays Loss of Ambulation by More Than Five Years
20 Sep 2021 //
PRNEWSWIRE
PTC aims again for FDA review of Duchenne drug despite latest miss
06 Feb 2021 //
BIOPHARMADIVE
PTC Therapeutics Announces First Publication of Real-World Data Translarnaä
03 Feb 2020 //
YAHOO
PTC Therapeutics Announces Translarna™ (ataluren)
04 Oct 2019 //
PR NEWSWIRE
AZ bags two extensions in latest CHMP decisions
01 Jul 2019 //
PHARMATIMES
Mallinckrodt doses first patient in muscular dystrophy trial
03 Aug 2018 //
PM LIVE
PTC Announces Positive Data from its Translarna™ Phase II Clinical Trial
09 Jul 2018 //
PR NEWSWIRE
PTC Announces + Ve Data from its Translarna™ PhII Clinical Trial
09 Jul 2018 //
PRESS RELEASE
CHMP Adopts Positive Opinion for the Expansion of the Translarna™ ataluren Label
01 Jun 2018 //
PRESS RELEASE
CHMP slaps down Sarepta but offers rival PTC an expanded market
01 Jun 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.